Your browser doesn't support javascript.
loading
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Bulluck, Heerajnarain; Fröhlich, Georg M; Nicholas, Jennifer M; Mohdnazri, Shah; Gamma, Reto; Davies, John; Sirker, Alex; Mathur, Anthony; Blackman, Daniel; Garg, Pankaj; Moon, James C; Greenwood, John P; Hausenloy, Derek J.
Afiliación
  • Bulluck H; Hatter Cardiovascular Institute, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
  • Fröhlich GM; Hatter Cardiovascular Institute, London, United Kingdom; Charité - Universitätsmedizin Berlin, Germany.
  • Nicholas JM; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Mohdnazri S; Essex Cardiothoracic Centre, Basildon, United Kingdom.
  • Gamma R; Essex Cardiothoracic Centre, Basildon, United Kingdom.
  • Davies J; Essex Cardiothoracic Centre, Basildon, United Kingdom.
  • Sirker A; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
  • Mathur A; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
  • Blackman D; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Garg P; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Moon JC; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom.
  • Greenwood JP; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Hausenloy DJ; Hatter Cardiovascular Institute, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom; National Heart Research Institute Singapor
Am Heart J ; 211: 60-67, 2019 05.
Article en En | MEDLINE | ID: mdl-30893577
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Ácido Canrenoico / Daño por Reperfusión Miocárdica / Antagonistas de Receptores de Mineralocorticoides / Intervención Coronaria Percutánea / Infarto del Miocardio con Elevación del ST Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Ácido Canrenoico / Daño por Reperfusión Miocárdica / Antagonistas de Receptores de Mineralocorticoides / Intervención Coronaria Percutánea / Infarto del Miocardio con Elevación del ST Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido